| May-19-22 11:14AM |
Will Idera Pharmaceuticals (NASDAQ:IDRA) Spend Its Cash Wisely? |
Simply Wall St. |
| May-17-22 11:59AM |
Why Are Idera Pharmaceuticals Shares Soaring Today |
Benzinga |
| May-17-22 10:53AM |
Healthcare Breakthroughs: IDRA, NMLSF, LMLLF, BBI; Life Sciences Leaders Report Latest Advances in Novel Therapeutics for Autism, Oncology, Autoimmune Diseases, and Glaucoma |
GlobeNewswire |
| May-17-22 08:04AM |
Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC |
GlobeNewswire |
| May-05-22 04:15PM |
Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Mar-31-22 04:15PM |
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Dec-14-21 04:32PM |
Idera Pharmaceuticals Announces Tilsotolimod Updates |
GlobeNewswire |
| Nov-08-21 04:14PM |
Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Aug-09-21 04:15PM |
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Jun-05-21 05:59AM |
Will Idera Pharmaceuticals (NASDAQ:IDRA) Spend Its Cash Wisely? |
Simply Wall St. |
| May-19-21 07:56AM |
Idera Will Not Continue Tilsotolimod/Ipilimumab Combo Melanoma Trial Into OS Primary Endpoint |
Benzinga |
| May-18-21 04:15PM |
Idera Pharmaceuticals Announces Corporate Updates |
GlobeNewswire |
| Apr-29-21 04:10PM |
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Mar-19-21 12:04PM |
Latest Biotech Flop Shows Risks of Trading in Penny Stocks |
Bloomberg |
| Mar-19-21 11:11AM |
Why Idera Pharmaceuticals Stock Is Crashing Today |
Motley Fool |
| Mar-19-21 10:03AM |
Benzinga's Top Ratings Upgrades, Downgrades For March 19, 2021 |
Benzinga |
| Mar-19-21 07:49AM |
Idera Pharmaceuticals stock plunges after disappointing trial results, prompting analyst downgrade |
MarketWatch |
| Mar-19-21 07:46AM |
The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs |
Benzinga |
| Mar-18-21 04:15PM |
Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma |
GlobeNewswire |
| Mar-18-21 08:56AM |
Are Options Traders Betting on a Big Move in Idera Pharmaceuticals (IDRA) Stock? |
Zacks |
| Mar-07-21 03:31AM |
When Will Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Become Profitable? |
Simply Wall St. |
| Mar-01-21 04:35PM |
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Mar-01-21 04:03PM |
Fluor-Led Joint Venture Opens 8-Mile 183 South Project in Austin, Texas |
Business Wire |
| Feb-28-21 02:49AM |
Fluors 2021 Earnings Outlook Disappoints; Stock Slips 13% |
SmarterAnalyst |
| Feb-26-21 06:50AM |
Fluor Reports Fourth Quarter and Full Year 2020 Results |
Business Wire |
| Jan-11-21 06:02AM |
Idera Pharmaceuticals to Present at Upcoming Conferences |
GlobeNewswire |
| Dec-18-20 02:22AM |
What Kind Of Shareholders Hold The Majority In Idera Pharmaceuticals, Inc.'s (NASDAQ:IDRA) Shares? |
Simply Wall St. |
| Dec-17-20 08:45AM |
Idera Pharmaceuticals (IDRA) in Focus: Stock Moves 9.4% Higher |
Zacks |
| Dec-15-20 08:05AM |
Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement of up to $20.7 Million |
GlobeNewswire |
| Dec-04-20 08:34AM |
Is Idera Pharmaceuticals (IDRA) A Good Stock To Buy Now? |
Insider Monkey |
| Nov-17-20 04:27PM |
Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer |
GlobeNewswire |
| Nov-03-20 07:10AM |
Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans? |
Simply Wall St. |
| Oct-29-20 04:36PM |
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update |
GlobeNewswire |
| Sep-28-20 08:45AM |
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037 |
GlobeNewswire |
| Sep-15-20 07:18AM |
Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020 |
GlobeNewswire |
| Sep-10-20 10:13AM |
Why Idera Pharmaceuticals' (NASDAQ:IDRA) CEO Pay Matters |
Simply Wall St. |
| Aug-04-20 04:10PM |
Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update |
GlobeNewswire |
| Jul-15-20 08:05AM |
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million |
GlobeNewswire |
| Jun-21-20 11:13PM |
Idera Pharmaceuticals Inc (IDRA): Hedge Funds Are Nibbling On |
Insider Monkey |
| Jun-02-20 08:15AM |
Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206 Trial for the Treatment of Micro-Satellite Stable Colorectal Cancer |
GlobeNewswire |
| May-01-20 08:00AM |
Idera Pharmaceuticals Announces Change of Location for 2020 Annual Meeting of Stockholders |
GlobeNewswire |
| Apr-30-20 04:35PM |
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update |
GlobeNewswire |
| Apr-23-20 07:30AM |
Idera Pharmaceuticals Announces Tilsotolimod Program Updates to be Presented at AACR Virtual Annual Meeting 2020 |
GlobeNewswire |
| Apr-21-20 07:30AM |
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma |
GlobeNewswire |
| Apr-10-20 01:49PM |
Insiders Roundup: Carnival, Bank Of New York Mellon |
GuruFocus.com |
| Apr-07-20 04:05PM |
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million |
GlobeNewswire |
| Mar-12-20 07:30AM |
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Mar-06-20 11:14AM |
Idera Completes Recruitment in Late-Stage Melanoma Study |
Zacks |
| Mar-05-20 07:00AM |
Idera Pharmaceuticals Completes Enrollment in ILLUMINATE-301, its Registrational Trial of Tilsotolimod in Combination with Ipilimumab in Patients with Anti-PD-1 Refractory Advanced Melanoma |
GlobeNewswire |
| Jan-14-20 07:00AM |
Idera Pharmaceuticals Provides 2020 Update and Outlook |
GlobeNewswire |
| Dec-24-19 12:05PM |
Exton biopharm could bring in nearly $100M through stock sale |
American City Business Journals |
| Dec-24-19 09:24AM |
Does Idera Pharmaceuticals, Inc.'s (NASDAQ:IDRA) CEO Salary Compare Well With Others? |
Simply Wall St. |
| Dec-23-19 09:15AM |
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million |
GlobeNewswire |
| Dec-16-19 04:39PM |
Should You Buy Idera Pharmaceuticals Inc (IDRA)? |
Insider Monkey |
| Nov-19-19 09:40AM |
Axovant's GM1 Gangliosidosis Candidate Gets Orphan Drug Tag |
Zacks |
| Nov-06-19 04:01PM |
Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial Results |
GlobeNewswire |
| Nov-01-19 10:03AM |
Baker Brothers Make $1.4 Billion in Two Weeks on Biotech |
Bloomberg |
| Oct-25-19 10:46AM |
Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Invest In Growth? |
Simply Wall St. |
| Oct-21-19 07:00AM |
Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037 |
GlobeNewswire |
| Sep-30-19 07:30AM |
Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors |
GlobeNewswire |
| Sep-10-19 09:33AM |
Easy Come, Easy Go: How Idera Pharmaceuticals (NASDAQ:IDRA) Shareholders Got Unlucky And Saw 85% Of Their Cash Evaporate |
Simply Wall St. |
| Sep-04-19 07:00AM |
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie |
GlobeNewswire |
| Aug-30-19 12:00PM |
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference |
GlobeNewswire |
| Aug-17-19 04:20AM |
Edited Transcript of IDRA earnings conference call or presentation 8-Aug-19 2:00pm GMT |
Thomson Reuters StreetEvents |
| Aug-08-19 10:15AM |
Idera Pharmaceuticals (IDRA) Reports Q2 Loss, Tops Revenue Estimates |
Zacks |
| Aug-08-19 09:00AM |
Idera Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2019 Financial Results |
GlobeNewswire |
| Aug-06-19 04:00PM |
Idera to Release 2019 Second Quarter Results on August 8, 2019 |
GlobeNewswire |
| Jul-25-19 10:33AM |
Idera Pharmaceuticals (IDRA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release |
Zacks |
| Jul-23-19 07:30AM |
Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial Officer |
GlobeNewswire |
| Jul-10-19 01:46PM |
Could The Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ownership Structure Tell Us Something Useful? |
Simply Wall St. |
| Jun-18-19 04:00PM |
Idera Pharmaceuticals to Present at the 2019 JMP Securities Life Sciences Conference |
GlobeNewswire |
| May-10-19 09:35AM |
Idera Pharmaceuticals, Inc. (IDRA) Shares March Higher, Can It Continue? |
Zacks |
| May-02-19 08:55PM |
Idera Pharmaceuticals (IDRA) Reports Q1 Loss, Lags Revenue Estimates |
Zacks |
| May-02-19 04:30PM |
Idera Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update |
GlobeNewswire |
| May-01-19 10:32AM |
Will Idera Pharmaceuticals (IDRA) Report Negative Q1 Earnings? What You Should Know |
Zacks |
| Apr-29-19 08:34AM |
Need To Know: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Insiders Have Been Buying Shares |
Simply Wall St. |
| Apr-10-19 07:00AM |
Idera Pharmaceuticals Provides Corporate Update |
GlobeNewswire |
| Apr-02-19 07:00AM |
Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting |
GlobeNewswire |
| Mar-14-19 11:21AM |
Life Sciences Pa. reveals awards for its top CEO, top products and deal of the year |
American City Business Journals |
| Mar-07-19 01:55PM |
If You Had Bought Idera Pharmaceuticals Stock Five Years Ago, Youd Be Sitting On A 94% Loss, Today |
Simply Wall St. |
| Mar-06-19 04:30PM |
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Feb-27-19 07:00AM |
Idera Pharmaceuticals Completes Enrollment Into the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment |
GlobeNewswire |
| Jan-23-19 12:55PM |
Idera acquires Travis CI |
TechCrunch |
| Jan-18-19 01:08PM |
How Much is Idera Pharmaceuticals, Inc.s (NASDAQ:IDRA) CEO Getting Paid? |
Simply Wall St. |
| Jan-04-19 07:30AM |
Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference |
GlobeNewswire |
| Dec-18-18 04:05PM |
Idera Pharmaceuticals Announces Appointment of Carol A. Schafer to its Board of Directors |
GlobeNewswire |
| Dec-17-18 07:00AM |
Today's Research Reports on Trending Tickers: Johnson & Johnson and Idera Pharmaceuticals |
ACCESSWIRE |
| Dec-14-18 07:00AM |
Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment |
GlobeNewswire |
| Dec-12-18 04:01PM |
Idera Pharmaceuticals to Provide ILLUMINATE-204 Clinical Data Update on Friday, December 14, 2018 |
GlobeNewswire |
| Dec-11-18 07:20AM |
United Parcel Service, Endurance International Group, Idera Pharmaceuticals, Aptevo Therapeutics, and Electro Scientific Industries Future Expectations, Projections Moving into 2018 |
GlobeNewswire |
| Dec-08-18 10:02AM |
The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings |
Benzinga |
| Nov-27-18 01:01PM |
How Many Idera Pharmaceuticals Inc (NASDAQ:IDRA) Shares Do Institutions Own? |
Simply Wall St. |
| Nov-06-18 06:35PM |
Idera Pharmaceuticals (IDRA) Reports Q3 Loss, Lags Revenue Estimates |
Zacks |
| Nov-06-18 05:32PM |
Idera: 3Q Earnings Snapshot |
Associated Press |
| Nov-06-18 04:30PM |
Idera Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Oct-19-18 06:00AM |
Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment at the 2018 European Society for Medical Oncology (ESMO) Congress |
GlobeNewswire |
| Oct-15-18 07:55AM |
Report: Developing Opportunities within Callon Petroleum, National Oilwell Varco, GameStop, Papa John's International, Baker Hughes, a GE company, and Idera Pharmaceuticals Future Expectations, Projections Moving into 2018 |
GlobeNewswire |
| Oct-11-18 08:34AM |
vTv Therapeutics (VTVT) Looks Good: Stock Adds 5.8% in Session |
Zacks |
| Sep-25-18 03:47PM |
What does Idera Pharmaceuticals Incs (NASDAQ:IDRA) Balance Sheet Tell Us About Its Future? |
Simply Wall St. |
| Sep-18-18 04:01PM |
Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors |
GlobeNewswire |